These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24475257)

  • 41. Serum levels of copper, zinc and disease severity scores in sickle cell disease patients in Benin City, Nigeria.
    Emokpae MA; Fatimehin EB; Obazelu PA
    Afr Health Sci; 2019 Sep; 19(3):2798-2805. PubMed ID: 32127853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracellular microvesicle microRNAs in children with sickle cell anaemia with divergent clinical phenotypes.
    Khalyfa A; Khalyfa AA; Akbarpour M; Connes P; Romana M; Lapping-Carr G; Zhang C; Andrade J; Gozal D
    Br J Haematol; 2016 Sep; 174(5):786-98. PubMed ID: 27161653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are there phases to the vaso-occlusive painful episode in sickle cell disease?
    Jacob E; Beyer JE; Miaskowski C; Savedra M; Treadwell M; Styles L
    J Pain Symptom Manage; 2005 Apr; 29(4):392-400. PubMed ID: 15857743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
    Dembélé AK; Lapoumeroulie C; Diaw M; Tessougue O; Offredo L; Diallo DA; Diop S; Elion J; Colin-Aronovicz Y; Tharaux PL; Jouven X; Romana M; Ranque B; Le Van Kim C
    Br J Haematol; 2021 Feb; 192(3):634-642. PubMed ID: 33249569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.
    Olatunya OS; Lanaro C; Longhini AL; Penteado CFF; Fertrin KY; Adekile A; Saad STO; Costa FF
    Ann Hematol; 2019 Nov; 98(11):2507-2521. PubMed ID: 31493004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis.
    Ekwere TA; Ebele U; Ekanem M; Ogunro PS
    Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
    Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
    Front Immunol; 2018; 9():322. PubMed ID: 29545790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease.
    Marsh A; Schiffelers R; Kuypers F; Larkin S; Gildengorin G; van Solinge W; Hoppe C
    Br J Haematol; 2015 Jan; 168(1):135-8. PubMed ID: 25196812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion.
    Brittain HA; Eckman JR; Swerlick RA; Howard RJ; Wick TM
    Blood; 1993 Apr; 81(8):2137-43. PubMed ID: 8471771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of splenectomy on circulating microparticles in patients with sickle cell anemia.
    Boulassel MR; Al-Rubkhi K; Al-Qasabi J; El-Ghamry I; Khan H; Panjwani V; Qureshi RN; Al-Mamari S; Al-Qarni Z; Al-Kindi M; Al-Nabhani A; Al-Gharibi K; Wali Y; Pathare A
    Int J Lab Hematol; 2024 Feb; 46(1):141-147. PubMed ID: 37661331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased adhesive and inflammatory properties in blood outgrowth endothelial cells from sickle cell anemia patients.
    Sakamoto TM; Lanaro C; Ozelo MC; Garrido VT; Olalla-Saad ST; Conran N; Costa FF
    Microvasc Res; 2013 Nov; 90():173-9. PubMed ID: 24144783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microfluidic study of enhanced deposition of sickle cells at acute corners.
    Loiseau E; Massiera G; Mendez S; Martinez PA; Abkarian M
    Biophys J; 2015 Jun; 108(11):2623-32. PubMed ID: 26039164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia.
    Bhatnagar P; Keefer JR; Casella JF; Barron-Casella EA; Bean CJ; Hooper CW; Payne AB; Arking DE; Debaun MR
    Pediatr Blood Cancer; 2013 Oct; 60(10):E125-7. PubMed ID: 23677903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
    Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
    N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection.
    Punyadee N; Mairiang D; Thiemmeca S; Komoltri C; Pan-Ngum W; Chomanee N; Charngkaew K; Tangthawornchaikul N; Limpitikul W; Vasanawathana S; Malasit P; Avirutnan P
    J Virol; 2015 Feb; 89(3):1587-607. PubMed ID: 25410854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of platelet activation in sickle cell anaemia.
    Ibanga IA
    Niger J Med; 2006; 15(2):148-50. PubMed ID: 16805172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disturbance of plasma and platelet thrombospondin levels in sickle cell disease.
    Browne PV; Mosher DF; Steinberg MH; Hebbel RP
    Am J Hematol; 1996 Apr; 51(4):296-301. PubMed ID: 8602630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
    Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating microparticles in severe preeclampsia.
    Marques FK; Campos FM; Filho OA; Carvalho AT; Dusse LM; Gomes KB
    Clin Chim Acta; 2012 Dec; 414():253-8. PubMed ID: 23041217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.
    Zhao L; Bi Y; Kou J; Shi J; Piao D
    J Exp Clin Cancer Res; 2016 Mar; 35():54. PubMed ID: 27015840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.